Drug Profile
Amlodipine/atenolol
Alternative Names: Atenolol/amlodipineLatest Information Update: 19 Mar 2019
Price :
$50
*
At a glance
- Originator Beijing Double-Crane Pharmaceutical
- Developer CR Double-Crane Pharmaceuticals
- Class Antihypertensives; Dihydropyridines; Ischaemic heart disorder therapies
- Mechanism of Action Beta 1 adrenergic receptor antagonists; Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Essential hypertension
Most Recent Events
- 19 Mar 2019 Discontinued - Phase-II for Essential hypertension in China (PO)